In this episode of On the Couch, I am joined by Jon Pilcher, the CEO of Neuren Pharma (NEU). We first chatted some three years ago, and NEU has delivered for investors since then. Good time for a catch-up as 2026 is going to be another big year.

Jon joined Neuren in 2013 as CFO and was appointed CEO in May 2020.

Neuren Pharmaceuticals (NEU) is developing new therapies for highly debilitating neurodevelopmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells.

Neuren's lead product trofinetide (also known as NNZ-2566) is licensed to Acadia Pharmaceuticals for North America, with Neuren retaining all rights outside North America and full access to all data generated by Acadia.

Some of the points we cover:

Talking Points.

• Neuren has gone from ‘pre-revenue option value’ to a profitable company with royalties pouring in. What do you think the market still misunderstands most about Neuren today?”
• DAYBUE is now the first and only approved treatment for Rett syndrome, with strong real-world persistence. What does the ‘second phase’ of growth look like as Acadia pushes deeper into community neurologists and global markets?
• How do you think about capital allocation now — offensive, defensive, or strategic optionality?” The share price peaked around A$25 but now sits closer to A$18 despite more data, more cash and less risk. What do you think drives that disconnect?
• NNZ-2591 looks like a true platform drug with multiple late-stage paths. If PMS, Pitt Hopkins and Angelman all succeed, how big could this franchise realistically become?
• Pitt Hopkins now has Fast Track, new patents, and an FDA meeting coming up. Could PTHS become your second registrational program — and how would that change Neuren’s scale?
• One of the things investors love about Neuren is that you’ve been able to fund everything from internal cashflow. Under what circumstances would you ever raise equity again?
• With DAYBUE expanding globally and NNZ-2591 entering multiple late-stage programs, what does Neuren look like in 3–5 years? A royalty engine, a commercial business… or something much bigger

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings sits down with Trade View Founder, Robert Bubalovski, to talk all things algo and AI in trading.

Robert founded Trade View 14 years ago with the goal of helping traders build their own models and systems – giving them the tools to harness algorithms, develop strategies, and take emotion out of the equation.

He's also affectionately known (at least by Henry) as The Trading Stig.

In this episode, Henry and Robert discuss:

• What is algo trading?
• How big an influence is it in markets today?
• Is today's market volatility being driven by algos?
• Why is algo trading so successful?
• Do you need special skills to do it well?
• Where does Trade View fit in?
• How does it help traders improve?
• Is this a way to compete with large institutions?
• How is AI changing the trading landscape?
• Is there still a place for traditional retail investors?
• What advice would Robert give to traders looking to take things to the next level?

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings sits down with trading mentor and author Louise Bedford – always a popular guest, offering valuable insights into markets and trading mentality.

Louise is a behavioural finance expert, bestselling author, and seasoned trader with over 30 years of experience. She hosts the Talking Trading podcast and is widely regarded as one of Australia's most compelling voices in the financial markets today.

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings is joined by his good friend and long-time market guru Jonathon Higgins from Unified Capital Partners – along with Jonathon's colleague, James Bisinella, Senior Equities Research Analyst at UCP in Melbourne.

Most listeners will already be familiar with Jonathon's valuable contributions over the years, and James brings his own sharp perspective to the table.

First of all, congratulations are in order – with some standout stock picks recently, it's fair to say their clients must be pretty happy.

Talking Points

• How should investors feel about the market right now?
• Is the hype in AI and tech starting to look overvalued – and is that a concern?
• Which sectors are worth watching for outperformance?
• What are your top three stocks to buy now – and why?
• ZIP has had a great run – can it keep going?
• EOL has been an absolute screamer from Jonathon – is there more to come?
• What risks or Black Swan events are on the radar right now?
• Where should investors be taking profits?

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings chats with Dr Mark Bennett, Non-Executive Chair at Falcon Metals (ASX: FAL).

Dr Bennett is a highly experienced geologist and mining executive with over 30 years' experience in gold and base metal exploration. He was the founding Managing Director and CEO of Sirius Resources (ASX: SIR), where he received the AMEC "Prospector of the Year Award" for the world-class Nova-Bollinger nickel-copper discovery in 2013.

Mark brings deep expertise in corporate affairs, equity capital markets, investor relations and community engagement. He led Sirius from pre-discovery all the way through to construction, before overseeing its merger with IGO.

He is currently Executive Chairman of S2 Resources (ASX: S2R) and a Non-Executive Director at Todd River Resources (ASX: TRT).

Talking Points

• A bit of background on Falcon Metals
• What attracted Mark to FAL?
• Why the strong share price performance in recent months – what's driving it?
• How is FAL doing things differently?
• Was Blue Moon the original focus?
• Blue Moon is shaping up nicely – some more colour on the current drilling campaign
• What kind of results are coming through?
• How much drilling is underway?
• What should investors watch for in the back half of 2025?

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings catches up with Jim Corbett from Avita Medical (ASX: AVH).

Jim was appointed CEO of AVITA Medical in September 2022, after serving on the Board since June 2021. He brings nearly 40 years of leadership experience in the medical device field, most recently as CEO of CathWorks Ltd., a software-based medical technology company.

Over the course of his career, Jim has served as CEO of three publicly listed companies and led two privately funded companies in the same role.

Talking Points

• First up, what does AVH do?
• Why is it the best treatment for burns?
• There was some disappointment with the recent results — why was that?
• Is sales growth stalling in the US? Is this a Trump-related issue?
• What's happening on the ground under the new administration?
• How is the new Medicare Administrative Contractor affecting revenue — and is there a solution?
• What are some positive catalysts shareholders can look forward to?
• What does the rest of the year hold?

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/

Welcome to the latest episode of On the Couch.

In this episode, Henry Jennings catches up with Morty Tollo, Co-Founder and CEO of Elbaite – Your Crypto, Your Way.

Founded in Melbourne in 2017, Elbaite set out to make cryptocurrency investing safer and more transparent for Australians. Since then, it has grown into a full-service crypto exchange, offering flexible investment options including SMSF portfolios, entity accounts, and professional trading services.

Talking Points

• Why is the crypto space attractive?
• What can you actually do with it?
• How much Bitcoin is used for transactions versus speculation?
• When pundits make bold Bitcoin price predictions, where do those numbers come from?
• How far could Bitcoin rally – and why?
• What are stablecoins?
• Why are they different?
• Could they be a game changer for the industry?
• What's the best way to play the crypto market?
• How do the mechanics work?
• With constant headlines about fraud and hacking, how can investors protect themselves?
• What does the future hold for digital currencies?
• Where does Elbaite fit into all of this?
• And the big question...Am I too late to this?

Disclaimer: This is general advice only. It doesn't take your personal circumstances into account. Please speak to a licensed adviser before acting on anything in this episode.

Looking for personal financial advice? Our friends at Clime Investment Management offer tailored advice and financial planning services across most states. Learn more: marcustoday.com.au/about-us/financial-planning-with-clime/

Prefer someone to invest for you? The Marcus Today Managed Strategy Portfolio applies the same strategy we write about daily – but we manage it for you, using Australian-listed ETFs and a long-term growth approach. Find out more: marcustoday.com.au/managed-portfolios/

Want to take control of your own investing? Start a free 14-day trial of the Marcus Today newsletter and get daily insights, analysis, and model portfolios designed for self-directed investors. Sign up here: marcustoday.com.au/trial-sign-up/